Episode Details

Back to Episodes

Exploring HER2-Low and Ultralow in GI Cancers, Newer Therapies Targeting HER2, and Current Testing Methods

Episode 426 Published 1 year, 11 months ago
Description
Drs. Benjamin Schlechter and Harshabad Singh discuss HER2-low and ultralow in GI cancers, newer therapies targeting HER2, and testing methods for HER in GI cancers.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us